C-reactive protein gene rs1205 polymorphism is not associated with the risk of colorectal cancer | Zendy

Dilong Fang | Zendy; Yu Ye | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

C-reactive protein gene rs1205 polymorphism is not associated with the risk of colorectal cancer

Author(s) -

Dilong Fang,

Yu Ye

Publication year - 2017

Publication title -

bioscience reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.938

H-Index - 77

eISSN - 1573-4935

pISSN - 0144-8463

DOI - 10.1042/bsr20170872

Subject(s) - odds ratio , meta analysis , colorectal cancer , genotype , medicine , c reactive protein , gene polymorphism , oncology , confidence interval , gene , bioinformatics , biology , genetics , cancer , inflammation

The relationship between C-reactive protein ( CRP ) gene rs1205 polymorphism and the risk of colorectal cancer (CRC) has been investigated previously. However, the results were conflicting. In the present study, we assessed whether CRP gene rs1205 polymorphism was associated with the risk of CRC by meta-analysis. We searched in PubMed, Embase, and the CNKI databases. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Seven original studies involving 4,181 cases and 10,601 controls analyzed the association between CRP gene rs1205 polymorphism and CRC risk. No significant association was found between CRP gene rs1205 polymorphism and CRC risk in this meta-analysis. Sensitivity analysis did not draw different findings. Stratification analyses of ethnicity, type of cancer, and genotype method also did not obtain any association between CRP gene rs1205 polymorphism and CRC risk. In conclusion, this meta-analysis indicates that CRP gene rs1205 polymorphism was not associated with the risk of CRC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research